Nurse Practitioner · Mooresville, NC
NPI
1104056167
Since 2009
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
131 Welton Way
Mooresville, NC, 28117
Phone (704) 360-4564
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
737 services
Medicare patients, 2024
56
Average age 66
Drug cost, 2024
$597K
2,930 prescriptions
Company payments, 2025
$1,539
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer M Drake was code 99214 (office e&m - established), 435 times for 54 patients. In total Jennifer M Drake billed 737 services in 12 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 435 | 54 | $72.67 | $32K |
| 80307 Drug Tests | Office | 127 | 42 | $59.09 | $7,504 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 91 | 32 | $190.96 | $17K |
By year: 2022 $73K for 896 services; 2023 $57K for 729 services; 2024 $63K for 737 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 127 | 42 | $59.09 | $7,504 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 91 | 32 | $190.96 | $17K |
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer M Drake prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 509 prescriptions and refills. In total Jennifer M Drake wrote 2,930 Medicare prescriptions that cost $597K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 509 | 509 | 81 | $14K |
| Pregabalin Generic | 361 | 381 | 56 | $6,830 |
| Oxycodone Hcl Generic | 272 | 272 | 37 | $5,186 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 271 | 271 | 50 | $9,235 |
| Belbuca Buprenorphine Hcl | 133 | 133 | 32 | $92K |
| Tramadol Hcl Generic | 114 | 114 | 18 | $1,219 |
| Tizanidine Hcl Generic | 106 | 116 | 15 | $472 |
| Morphine Sulfate Er Morphine Sulfate | 103 | 103 | 22 | $2,548 |
| Movantik Naloxegol Oxalate | 98 | 98 | 25 | $39K |
| Gabapentin Generic | 95 | 95 | 24 | $945 |
| Xtampza Er Oxycodone Myristate | 83 | 83 | 11 | $47K |
| Morphine Sulfate Generic | 74 | 74 | 20 | $1,683 |
| Cyclobenzaprine Hcl Generic | 70 | 70 | 12 | $448 |
| Levorphanol Tartrate Generic | 63 | 63 | Under 11 | $170K |
| Naloxone Hcl Generic | 54 | 62 | 51 | $3,384 |
Brand drugs: 626 claims; generic drugs: 2,304 claims; opioid claims: 1,682.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer M Drake $1,539 ($1,539 in general payments such as food, travel and fees) from 13 companies. The largest payer was Pfizer Inc. with $312.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 10 | $312 |
| Indivior Inc. INDV | 3 | $195 |
| Abbvie Inc. ABBV | 13 | $187 |
| Novo Nordisk Inc NVO | 5 | $178 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 8 | $177 |
| Forte Bio-Pharma LLC | 5 | $107 |
| Collegium Pharmaceutical, Inc. COLL | 5 | $96.14 |
| Vertex Pharmaceuticals Incorporated VRTX | 3 | $83.88 |
| Scilex Pharmaceuticals Inc. | 4 | $71.07 |
| Virtus Pharmaceuticals LLC | 3 | $55.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.